Stopper and method for translating same in a tube
A silicone-free stopper design with polymeric ribs and microgrooves, guided by an insertion pin, addresses distortion and sliding force issues in syringes, ensuring impermeability and seal integrity for pharmaceutical compositions.
Patent Information
- Application Number
- JP2023530616
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-11-20
- Filing Date
- 2021-11-19
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2041-11-19
AI Technical Summary
Conventional syringe stoppers made of rubber or elastomeric materials face issues with air and liquid impermeability, distortion during assembly, and inconsistent sliding forces, which can lead to leakage and adverse effects on pharmaceutical compositions.
A silicone-free stopper design with a polymeric barrier featuring ribs and microgrooves, guided by an insertion pin with a shoulder and force concentrators, minimizes distortion and enhances sliding forces during assembly and use.
The solution ensures air and liquid impermeability, reduces distortion, and maintains acceptable sliding forces, thereby preventing leakage and maintaining container seal integrity while preserving the integrity of pharmaceutical compositions.
Smart Images

Figure 0007594113000001 
Figure 0007594113000002 
Figure 0007594113000003
Abstract
Description
[Technical field]
[0001] FIELD OF THE DISCLOSURE The present disclosure relates generally to medical devices such as syringes, and in particular to stoppers and methods for translating the stoppers through tubing. [Background technology]
[0002] Medical delivery devices, including syringes and prefilled syringes, function to store and deliver drugs and biological substances (e.g., pharmaceuticals and / or biotherapeutics). Prefilled syringes generally provide cost savings to the pharmaceutical industry and can improve the safety, convenience and efficiency of drug delivery. Biopharmaceuticals are an important class of drugs that can utilize the use of prefilled syringes and related devices such as autoinjectors. Non-limiting examples of such biopharmaceuticals include insulin, vaccines, antibodies, blood products, hormones and / or cytokines.
[0003] These types of medical delivery devices typically include a container (e.g., a syringe barrel or cartridge tube) for receiving a liquid, a plunger rod reciprocable within the container, and a stopper that is typically attached to the end of the plunger rod. Air and liquid impermeability can minimize or eliminate liquid leakage within the container and can minimize or eliminate the introduction of air between the outer surface of the stopper and the inner wall of the container when filling or dispensing liquid into or from the container. Low sliding forces facilitate filling and dispensing of liquid within the container. In addition to these requirements, medical syringes must not adversely affect pharmaceutical compositions, particularly biopharmaceuticals, that come into contact with the stopper.
[0004] Stoppers used in conventional barrels and tubes are generally made of rubber or other elastomeric materials. Conventional stoppers may have sufficient air and liquid impermeability, but may not have acceptable sliding force. Therefore, silicone and / or liquid lubricants may be applied to the outer surface of the stopper and / or the inner wall of the barrel or cartridge tube to enhance the sliding properties of the stopper. However, syringes containing lubricants such as silicone lubricants may cause inactivation or otherwise adversely affect the efficacy of the pharmaceutical composition.
[0005] To enhance low friction sliding and stability of pharmaceutical compositions, stoppers laminated or coated with at least one layer, such as at least one fluoropolymer layer, have been used. However, it has been observed that stoppers with fluoropolymer layers may not function consistently during their assembly and / or use. For example, the stoppers may distort during insertion of the stopper into a barrel or cartridge tube and / or during movement of the plunger rod within the barrel or cartridge tube during use. Such distortion may create leakage paths for liquids or otherwise adversely affect the functionality and / or appearance of the stopper. Summary of the Invention [Problem to be solved by the invention]
[0006] Thus, a need exists for a stopper that is air and liquid impermeable, does not distort upon insertion, and provides an acceptable sliding force. Additionally, a need exists for a method of translating the stopper through a barrel, cartridge tube, or vent or insertion tube, particularly through a lubricant-free or substantially lubricant-free barrel, cartridge tube, and / or vent or insertion tube, such that the stopper does not distort during the assembly process and / or use of the stopper. [Means for solving the problem]
[0007] According to a first embodiment ("Example 1"), the method includes placing a distal end of a stopper in a proximal end of an insertion tube, the insertion tube and the stopper being silicone-free, the stopper including a plunger rod engaging cavity and a seal region having a predetermined length spaced apart from the proximal end of the stopper by a seal location length, the seal region having at least one rib including at least one microgroove in a polymer barrier, the at least one microgroove having an initial width. The method includes positioning an insertion pin in the proximal end of the stopper without contacting the distal region of the plunger rod engaging cavity. The insertion pin has a cylindrical body including a distal end having a shoulder and a pin tip having a diameter smaller than the diameter of the plunger rod engaging cavity. The method further includes contacting the proximal end of the stopper with the shoulder of the insertion pin and applying a force to the proximal end of the insertion pin such that the increase in the initial width of the at least one microgroove is reduced by at least 10%.
[0008] According to another embodiment ("Example 2") in addition to Example 1, the method includes guiding the stopper through the entire length of the insertion tube and into the syringe barrel, the syringe barrel being silicone-free.
[0009] According to another embodiment ("embodiment 3") in addition to embodiment 2, the insertion pin engages a distal end region of the plunger rod engagement cavity when guiding the stopper through the insertion tube.
[0010] According to another embodiment ("embodiment 4") in addition to any one of the preceding embodiments, in the step of placing the distal end of the stopper on the proximal end of the insertion tube, the stopper is in an uncompressed state.
[0011] According to another embodiment ("embodiment 5") in addition to any one of embodiments 2-4, in the step of guiding the stopper through the insertion tube, the stopper is in a compressed state.
[0012] According to another embodiment ("Example 6") in addition to any one of the preceding embodiments, applying a force to a proximal end of the insertion pin includes transmitting at least a portion of the force to a proximal end of the stopper.
[0013] According to another embodiment ("Example 7") in addition to Example 6, the method includes transmitting at least a portion of a force to a proximal end of the stopper, the method including applying one or both of: (1) a first force to the proximal end of the stopper or (2) a second force to a distal end of the plunger rod engagement cavity.
[0014] According to another embodiment ("Example 8") in addition to any one of the preceding embodiments, the shoulder of the insertion pin includes at least one force concentrating feature including an annular structure extending from the shoulder of the insertion pin, optionally including at least one of a flat, sharp, or rounded surface configured to engage the proximal end of the stopper.
[0015] According to another embodiment ("Example 9") in addition to any one of the preceding embodiments, the proximal end of the stopper includes at least one force concentrating feature including an annular structure extending from the proximal end of the stopper, optionally including at least one flat, sharp, or rounded surface configured to engage an insertion pin.
[0016] According to another embodiment ("Example 10") in addition to Examples 8 or 9, the at least one concentration feature is configured such that a force applied to the stopper is biased toward an outer diameter of the stopper, such that the force is applied to at least an annular surface at a proximal end of the stopper.
[0017] According to another embodiment ("Example 11") in addition to any one of the preceding embodiments, the sealing area includes a first rib and a second rib, and a force applied to the proximal end of the insertion pin is applied such that the length between the first rib and the second rib has a decrease in increase of at least 1%.
[0018] According to another embodiment ("Example 12") in addition to any one of the preceding embodiments, the reduction in the increase in the initial width of the microgrooves is at least 15%.
[0019] According to another embodiment ("Example 13"), a method of dispensing contents of a syringe barrel includes inserting a plunger rod into a proximal end of a plunger rod engagement cavity of a stopper, the stopper being silicone-free, the stopper having a proximal end opposite a distal end and a seal region having a length spaced from the proximal end by a seal location length, the seal region including a polymer barrier and at least one microgroove having an initial width and positioned within the polymer barrier, the method including contacting the proximal end of the stopper with a shoulder of the plunger rod in a syringe barrel without contacting the distal region of the plunger rod engagement cavity, the syringe barrel being silicone-free and containing a therapeutic agent. The method further includes applying a force to the plunger rod such that a decrease in the increase in the initial width of the at least one microgroove is at least 10%.
[0020] According to another embodiment ("Example 14") in addition to Example 13, the method includes guiding the stopper through the syringe barrel by transmitting at least a portion of a force applied to the plunger rod to a proximal end of the stopper.
[0021] According to another embodiment ("Example 15") in addition to Example 14, the shoulder of the plunger includes at least one force concentrating feature including an annular structure extending from the shoulder of the plunger rod, optionally including at least one flat, sharp, or rounded surface configured to engage the proximal end of the stopper.
[0022] According to another embodiment ("Example 16") in addition to Example 14, the proximal end of the stopper includes at least one force concentrating feature including an annular structure extending from the proximal end of the stopper, optionally including one of a flat, sharp, or rounded surface configured to engage a shoulder of the plunger rod.
[0023] According to another embodiment ("Example 17") in addition to any one of Examples 14-16, the plunger rod includes a distal end having a shoulder and a plunger rod tip, the plunger rod tip being configured to be received by a distal region of the plunger rod engagement cavity of the stopper.
[0024] According to another embodiment ("Example 18") in addition to Example 17, when guiding the stopper through the syringe, the plunger rod tip engages a distal region of the plunger rod engagement cavity of the stopper.
[0025] According to another embodiment ("Example 19") in addition to Example 18, applying a force to the plunger rod includes applying one or both of: (1) a first force to a proximal end of the stopper, or (2) a second force to a distal end of the plunger rod engagement cavity.
[0026] According to another embodiment ("Example 20") in addition to any one of Examples 13-19, the sealing area of the stopper includes a first rib and a second rib, a rib length extends between the first rib and the second rib, and a force is applied to the plunger rod such that the rib length reduces with increasing at least 1%.
[0027] According to any one of Examples 13-20 plus another Example ("Example 21"), the reduction in the increase in initial width of at least one microgroove is at least 15%.
[0028] According to another embodiment ("Embodiment 22") in addition to embodiment 13, the stopper and the plunger rod are not directly attached.
[0029] According to another embodiment ("embodiment 23") in addition to any one of embodiments 16-19, the at least one force concentrating feature is configured such that a force is applied to at least an annular surface of the proximal end of the stopper such that the force applied to the stopper is biased toward an outer diameter of the stopper.
[0030] According to another embodiment ("Example 24") in addition to any one of Examples 13-23, the method further includes delivering a therapeutic agent contained within the syringe barrel.
[0031] According to another embodiment ("embodiment 25") in addition to any one of embodiments 13-24, the stopper is in a compressed state. [Brief description of the drawings]
[0032] The accompanying drawings are provided to provide a further understanding of the disclosure, are incorporated in and constitute a part of this specification, illustrate embodiments, and together with the description, help to explain the principles of the disclosure.
[0033] [Figure 1A] FIG. 1A is a schematic cross-sectional view of a syringe according to some embodiments.
[0034] [Figure 1B] FIG. 1B is a schematic cross-sectional view of a cartridge tube according to some embodiments.
[0035] [Diagram 2] FIG. 2 is a cutaway view of a stopper according to some embodiments.
[0036] [Diagram 3] FIG. 3 is a cutaway view of a stopper according to some embodiments.
[0037] [Figure 4] FIG. 4 is a detailed side view of a portion of a stopper showing ribs and microgrooves according to some embodiments.
[0038] [Diagram 5] FIG. 5 is a detailed cross-sectional view of a portion of the stopper as shown in FIG. 4 according to some embodiments.
[0039] [Figure 6]FIG. 6 is a detailed side view of a portion of a stopper showing ribs and microgrooves according to some embodiments.
[0040] [Figure 7] FIG. 7 is a cutaway view of a stopper according to some embodiments.
[0041] [Figure 8A] FIG. 8A is a schematic side view of a plunger rod according to some embodiments.
[0042] [Figure 8B] FIG. 8B is an end view of the plunger rod shown in FIG. 8A according to some embodiments.
[0043] [Figure 9] FIG. 9 is a cross-sectional view of a vent or insertion tube according to some embodiments.
[0044] [Figure 10A] FIG. 10A is a schematic perspective view of an insertion pin according to some embodiments.
[0045] [Figure 10B] FIG. 10B is a cross-sectional side view of the insertion pin shown in FIG. 10A.
[0046] [Figure 11A] FIG. 11A is an illustration of a portion of a stopper and the various forces that impinge on the stopper during insertion and translation through a barrel or cartridge tube, according to some embodiments. [Figure 11B] FIG. 11B is an illustration of a portion of a stopper and the various forces that impinge on the stopper during insertion and translation through a barrel or cartridge tube, according to some embodiments. [Figure 11C] FIG. 11C is an illustration of a portion of a stopper and the various forces impinging on the stopper during insertion and translation through a barrel or cartridge tube, according to some embodiments. [Figure 11D] FIG. 11D is an illustration of a portion of a stopper and the various forces impinging on the stopper during insertion and translation through a barrel or cartridge tube, according to some embodiments.
[0047] [Figure 12A] FIG. 12A is an illustration of a portion of a stopper having a cavity therein and the various forces impinging on the stopper upon insertion and / or translation through a barrel or cartridge tube, according to some embodiments. [Figure 12B] FIG. 12B is an illustration of a portion of a stopper having a cavity therein and the various forces impinging on the stopper upon insertion and / or translation through a barrel or cartridge tube, according to some embodiments. [Figure 12C] FIG. 12C is an illustration of a portion of a stopper having a cavity therein and various forces impinging on the stopper upon insertion and / or translation through a barrel or cartridge tube, according to some embodiments. [Figure 12D] FIG. 12D is an illustration of a portion of a stopper having a cavity therein and the various forces impinging on the stopper upon insertion and / or translation through a barrel or cartridge tube, according to some embodiments.
[0048] [Figure 13A] FIG. 13A is an illustration of a microgroove having a thickness less than the thickness of the polymer layer according to some embodiments.
[0049] [Figure 13B] FIG. 13B is an illustration of a microgroove having a thickness equal to the thickness of the polymer layer according to some embodiments.
[0050] [Figure 13C] FIG. 13C is an illustration showing the overall extension of the stopper and associated microgroove extension within a barrel or cartridge tube according to some embodiments. [Figure 13D] FIG. 13D is an illustration showing the overall extension of the stopper and associated microgroove extension within a barrel or cartridge tube according to some embodiments.
[0051] [Figure 14] FIG. 14 is a cutaway view of a stopper according to some embodiments.
[0052] [Figure 15] FIG. 15 is a schematic cross-sectional view of an insertion pin according to some embodiments.
[0053] [Figure 16] FIG. 16 is a schematic cutaway view of the insertion pin shown in FIG. 15 engaged with a stopper according to some embodiments.
[0054] [Figure 17] FIG. 17 is a schematic cross-sectional view of an insertion pin according to some embodiments.
[0055] [Figure 18] FIG. 18 is a schematic cutaway view of the insertion pin shown in FIG. 17 engaged with a stopper according to some embodiments.
[0056] [Figure 19] FIG. 19 is a schematic cross-sectional view of an insertion pin, according to some embodiments.
[0057] [Figure 20A] FIG. 20A is a schematic partial cross-sectional view of the insertion pin shown in FIG. 19 engaged with a stopper according to some embodiments. [Figure 20B] FIG. 20B is a schematic partial cross-sectional view of the insertion pin shown in FIG. 19 engaged with a stopper according to some embodiments.
[0058] [Figure 21] FIG. 21 is a schematic cross-sectional view of an insertion pin, according to some embodiments.
[0059] [Figure 22A] FIG. 22A is a schematic partial cross-sectional view of the insertion pin shown in FIG. 19 engaged with a stopper according to some embodiments. [Figure 22B] FIG. 22B is a schematic partial cross-sectional view of the insertion pin shown in FIG. 19 engaged with a stopper according to some embodiments.
[0060] [Figure 23A] FIG. 23A is a schematic cutaway view of an insertion pin including a force concentrator engaged with a stopper according to some embodiments. [Figure 23B] FIG. 23B is a schematic cutaway view of an insertion pin including a force concentrator engaged with a stopper according to some embodiments. [Figure 23C] FIG. 23C is a schematic cutaway view of an insertion pin including a force concentrator engaged with a stopper according to some embodiments. [Figure 23D] FIG. 23D is a schematic cutaway view of an insertion pin including a force concentrator engaged with a stopper according to some embodiments.
[0061] [Figure 24A] FIG. 24A is a cutaway view of a stopper including a force concentrator according to some embodiments. [Figure 24B] FIG. 24B is a cutaway view of a stopper including a force concentrator according to some embodiments. [Figure 24C] FIG. 24C is a cutaway view of a stopper including a force concentrator according to some embodiments. [Figure 24D] FIG. 24D is a cutaway view of a stopper including a force concentrator according to some embodiments.
[0062] [Figure 25A] FIG. 25A is a schematic illustration of various shapes of force concentrator locations at the distal end of the plunger rod according to some embodiments. [Figure 25B]FIG. 25B is a schematic illustration of various shapes of force concentrator locations at the distal end of the plunger rod according to some embodiments. [Figure 25C] FIG. 25C is a schematic illustration of various shapes of force concentrator locations at the distal end of the plunger rod according to some embodiments. [Figure 25D] FIG. 25D is a schematic illustration of various shapes of force concentrator locations at the distal end of the plunger rod according to some embodiments. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0063] definition Those skilled in the art will readily appreciate that the various aspects of the disclosure may be implemented by a variety of methods and apparatus configured to perform the intended functions. It should also be appreciated that the accompanying drawings referred to herein are not necessarily to scale and may be exaggerated to illustrate the various aspects of the disclosure, and that the drawings should not be construed as limiting in that regard.
[0064] It should be appreciated that "barrel" and "syringe barrel" may be used interchangeably herein. Additionally, "tube", when not used in conjunction with "cartridge", refers to any of a number of tubular structures through which a stopper may be inserted and / or translated during the assembly process and / or use of a syringe or cartridge, such as, but not limited to, a stopper receiving opening of a transfer bar, such as a flip bar or a rotating bar, a vent, a vacuum or insertion tube, a barrel of a syringe and / or a cartridge tube of an autoinjector. It should be noted that "lubricant-free syringe barrel" and "lubricant-free barrel" are interchangeable in this disclosure with "lubricant-free cartridge tube". Also, "polymer or oriented polymer layer" may be used interchangeably in this disclosure with "laminate layer". Additionally, "syringe" and "cartridge tube" may be used interchangeably in this disclosure. Also, as used herein, "about" means ±10% of the unit of measurement specified.
[0065] Syringe The present disclosure relates to stoppers and methods of translating the stoppers through lubricant-free or substantially lubricant-free barrels, cartridge tubes, and / or vents or insertion tubes during the assembly process and / or use of the stoppers such that the stoppers do not distort or otherwise render the barrel or cartridge tube containing the stoppers unusable. As used herein, "lubricant-free" means that no liquid lubricant is intentionally added or the amount of liquid lubricant present is below detectable levels. Lubricant-free can include silicone lubricant-free. Embodiments relate to methods of using insertion tubes and insertion pins to move or translate stoppers having polymer layers (e.g., fluoropolymer or expanded fluoropolymer layers) or laminate layers into lubricant-free or substantially lubricant-free barrels or lubricant-free or substantially lubricant-free cartridge tubes. Embodiments also relate to a method of using a funnel-shaped vacuum insertion tube to move or translate a stopper having a body (e.g., an elastomeric body) and a polymeric or laminate layer bonded to or associated with the body into a lubricant-free or substantially lubricant-free barrel or a lubricant-free or substantially lubricant-free cartridge tube. Embodiments also relate to a method of inserting a stopper into a vent or insertion tube in a transfer bar system in connection with an assembly process of a syringe or cartridge tube. Embodiments also relate to a method of moving or translating a stopper into and through a syringe barrel or cartridge tube during an assembly process and / or use of a syringe or autoinjector device. These embodiments provide container closure integrity (CCI), acceptable sliding forces, and other properties of syringes and cartridges and their uses.
[0066] The stopper may include an elastomeric body and a polymer or oriented polymer layer or laminate layer at least partially covering the elastomeric body. As used herein, "syringe" and "cartridge" refer to any device that delivers at least one therapeutic compound (e.g., a drug or biological agent) by injection through a needle or through a "needleless" system (e.g., a Luer system) that translates the stopper. The syringe or autoinjector can be used to administer a variety of therapeutic compounds, such as drugs and biological agents, including, but not limited to, antibodies, antisense, RNA interference, gene therapy, primary and embryonic stem cells, vaccines, and combinations thereof. The following disclosure applies equally to the syringe or cartridge and to the assembly and use of these devices. Various types of therapeutic delivery devices, such as syringes, autoinjectors, or injection pens, are envisioned and are considered to be within the scope of this disclosure.
[0067] FIG. 1A illustrates a syringe 10 according to some embodiments. As illustrated, the syringe 10 can include a barrel 20 having an inner surface 25 and a piercing element (e.g., needle) 30 or coupling (e.g., using a Luer connection feature) feature (not shown) attached thereto for injecting a therapeutic compound. A plunger rod 50 can include a stopper 40 secured to a distal end of the plunger rod 50. The stopper 40 has an outer surface 41 that contacts at least a portion of the inner surface 25 of the barrel 20 via one or more ribs 42, 44 that extend around the circumference of the stopper. Although two ribs 42, 44 are shown in FIG. 1A, any number of ribs can be present on the stopper 40. At least one of the ribs 42, 44 is a sealing rib. In some embodiments, the rib 42 is the only sealing rib. Hereinafter, the ribs 42, 44 will both be referred to as sealing ribs in the discussion. The sealing ribs 42, 44 provide container seal integrity to the barrel 20 of a prefilled syringe or cartridge tube of an autoinjector. The stopper 40 further includes a cavity 48, also referred to herein as a plunger rod engagement cavity, that can be used to receive a plunger rod 50 or various other translation elements, as described below. One or more flanges 70 can be used as finger grips to push and translate the plunger rod 50 within the syringe barrel 20.
[0068] FIG. 1B illustrates a cartridge 33 according to some embodiments. In the illustrated embodiment of the cartridge 33, the modified plunger rod (not shown) and stopper 65 are not attached. In this manner, the modified plunger rod can be a floating plunger rod within the cartridge 33 such that the modified plunger rod floats within the cartridge 33 prior to contacting the stopper 65. However, after contacting the stopper 65, the modified plunger rod is in contact with the stopper 65 during translation of the stopper 65. While the illustrated embodiment of the stopper 65 does not have a cavity therein, other embodiments can include a cavity for receiving the plunger rod, for example, as shown in FIG. 1A. The stopper 65 contacts at least a portion of the inner surface 25 of the cartridge tube 35 via one or more ribs, such as sealing ribs 42 and 44. The cartridge 33 includes a stopper 65, a sealing cap 34, a cartridge tube 35, and a sealing end portion 36. The sealing end portion 36 may be an open end of the cartridge 33 that may be sealed when used with the stopper 40. It should be appreciated that the components of the syringe 10 and the cartridge 33 may be lubricant-free or substantially lubricant-free, as described below.
[0069] Stopper The stopper 40 includes an elastomeric body that is at least partially laminated, coated or otherwise covered with a polymer or oriented polymer layer. In some embodiments, the elastomeric body can have one or more polymer or oriented polymer layers thereon.
[0070] For example, FIG. 2 illustrates a stopper 40 having an elastomeric body 125 and a polymer or oriented polymer layer 140. In some embodiments, the polymer or oriented polymer layer can include a single layer of polymer or oriented polymer that at least partially covers the elastomeric body 125. In some embodiments, the polymer or oriented polymer layer 140 surrounds or covers the elastomeric body 125. FIG. 3 illustrates another embodiment of a stopper 40 including an elastomeric body 125 and a laminate layer 130 that can be formed of a polymer or oriented polymer layer 140 (e.g., expanded fluoropolymer) and a porous layer 150. As mentioned above, the stopper 40 can have one or more sealing ribs, such as sealing ribs 42, 44 extending therefrom. In some embodiments, the ribs 42 and 44 include microgrooves 133, which are described in more detail below.
[0071] In some embodiments, the polymer is a fluoropolymer (which may be an expanded fluoropolymer). Examples of fluoropolymers that can be utilized as the polymer or expanded polymer layer 140 or as the porous layer 150 include polytetrafluoroethylene (PTFE), expanded polytetrafluoroethylene (expanded PTFE), compressed expanded polytetrafluoroethylene (expanded PTFE), compressed polytetrafluoroethylene (PTFE), expanded modified polytetrafluoroethylene (PTFE), expanded copolymers of polytetrafluoroethylene (PTFE), ethylene-(perfluoroethylene propylene) copolymers (EFEP), polyvinylidene fluoride (PVDF), fluorinated ethylene propylene (FEP), perfluoroalkoxy copolymer resins (PFA), polyvinyl fluoride, perfluoropropyl vinyl ether, and perfluoroalkoxy polymers. Expandable blends of PTFE, expandable modified PTFE and expandable copolymers of PTFE have been patented, such as, but not limited to, U.S. Patent No. 5,708,044 to Branca, U.S. Patent No. 6,541,589 to Baillie, U.S. Patent No. 7,531,611 to Sabol et al., U.S. Patent No. 8,637,144 to Ford, and U.S. Patent No. 9,139,669 to Xu et al. Non-fluoropolymers such as polyethylene, polypropylene or polycarbonate can also be used as the polymer or expanded polymer layer 140.
[0072] Non-limiting examples of elastomers that can be used to form the elastomeric body 125 include any elastomer suitable for the application, most notably rubbers formed from butyl, bromobutyl, chlorobutyl, halobutyl, silicone, nitrile, styrene butadiene, polychloroprene, ethylene propylene diene, fluoroelastomers, thermoplastic elastomers (TPEs), thermoplastic vulcanizates (TPVs), and combinations and mixtures thereof.
[0073] The polymer or oriented polymer layer 140 can be characterized by a thickness T. In some embodiments, the thickness T is a distance between about 1 μm and about 50 μm, about 5 μm and about 40 μm, about 5 μm and about 20 μm, or about 20 μm and about 30 μm. The laminate layer 130 can have a thickness (T) less than about 30 μm. In some embodiments, the thickness of the laminate layer 130 can range from about 0.5 μm to about 20 μm, about 0.5 μm to about 10 μm, or about 10 μm to about 30 μm. The layers forming the polymer or oriented polymer layer 140 (e.g., FIG. 2) and / or the porous layer 150 (e.g., FIG. 3) can be pre- or post-treated with chemical etching, plasma treatment, corona treatment, rough machining, or the like to improve adhesion of the polymer or oriented polymer layer 140 and / or the porous layer 150 to the elastomeric body 125. The materials of the laminate layer 130 and the polymer or oriented polymer layer 140 are selected to provide a low coefficient of friction, compliance, low extractables and exudates, excellent barrier properties related to extractables and exudates from the elastomeric body 125, and excellent air and liquid impermeability. In another embodiment, the polymer or oriented polymer layer 140 can be used with non-elastomeric materials such as, but not limited to, plastics (e.g., polypropylene, polycarbonate, and polyethylene), thermoplastics, and fluoropolymer materials such as ethylene-(perfluoroethylene propylene) copolymers (EFEP), polyvinylidene fluoride (PVDF), and perfluoroalkoxy polymer resins (PFA).
[0074] FIG. 4 is a schematic diagram of a portion of a sealing rib 44 of a stopper 40 according to some embodiments. Although the description herein is primarily directed to the use of the stopper 40, the stopper 65 can be used interchangeably with the stopper 40. Although only one sealing rib 44 having microgrooves 133 is shown in FIGS. 4 and 5 as an example, one or more additional sealing ribs (such as rib 42 on the stopper 40) can have the same or substantially the same microgrooves 133 as the sealing rib 44. As shown, the rib 44 can be characterized as extending from a major surface of the outer side of the stopper 40 by a height H5 (FIG. 5) and having a width W1 (i.e., in a direction parallel to the longitudinal axis 39 of the stopper as shown in FIG. 2). In some embodiments, the height H5 is a distance of about 1 μm to about 500 μm, about 3 μm to about 400 μm, about 200 μm to about 400 μm, or about 250 μm to about 350 μm. Width W1, in some embodiments, is a distance between about 5 μm and 400 μm, between about 10 μm and about 300 μm, or between about 200 μm and about 300 μm. Other embodiments of stopper 40 include sealing ribs, such as rib 44, having heights H5 and widths W1 that are greater or less than the distances described herein.
[0075] As shown in FIGS. 4 and 5, the rib 44 includes microgrooves 133 (ribs 42 not shown) extending from its outer surface into the rib 44. The microgrooves 133 extend circumferentially within the rib 44. In FIGS. 4 and 5, the microgrooves 133 have a width W2 and a depth D2. The width W2 can be a distance of about 5 μm to about 300 μm, about 5 μm to about 150 μm, about 5 μm to about 50 μm, or about 10 μm to about 30 μm. The depth D2 can be a distance of about 1 μm to about 50 μm, about 5 μm to about 30 μm, or about 5 μm to about 15 μm. In some embodiments, the depth D2 is equal to the thickness T of the polymer or oriented polymer layer 140 or the thickness T′ of the laminate layer 130. The elastomeric material of the elastomeric body 125 can be exposed by the microgrooves 133. In other embodiments, the depth D2 of the microgrooves 133 is less than the thickness T of the polymer or oriented polymer layer 140 or the thickness T' of the laminate layer 130. In some embodiments, for example, the depth D2 is about 10% to about 95%, about 30% to about 95%, about 50% to about 95%, or about 75% to about 95% of the thickness T, T' of the polymer or oriented polymer layer 140 or the laminate layer 130, respectively. Other embodiments of the stopper 40 having sealing ribs 42, 44 with microgrooves 133 can have greater or lesser heights H5, widths W2, and depths D2.
[0076] The microgrooves 133 are continuous in the embodiment shown in Figures 4 and 5. In other embodiments, the microgrooves 133 can be discontinuous. For example, Figure 6 shows a stopper 40 having discontinuous microgrooves 133' that include a plurality of discrete openings 136 that extend to a depth D2 or any value less than the depth D2. For example, the openings 136 can extend to a depth having a value between 5% and 100%, 10% and 80%, 15% and 70%, 25% and 60%, or 35% and 50% of the depth D2. Microgrooves such as 133 and 133' can be formed by any suitable manufacturing process known or otherwise conventional, such as, but not limited to, a laser, laser ablation, or by a mechanical cutting or puncturing device, such as a blade.
[0077] 7 illustrates various features of the stopper 40. The stopper 40 is configured to obtain a CCI with a high level of air and liquid impermeability while maintaining an acceptably low break-loose and sliding force. The stopper 40 includes a body 205 having opposed proximal and distal ends 210 and ribs, such as ribs 42, 44. At least one of the ribs 42, 44 is laminated with a polymer or oriented polymer layer 140. The cavity 48 is configured to receive a plunger rod (not shown) and has a depth extending into the body from the proximal end 210 to the distal end 215 of the body 205. The proximal end 210 includes a generally annular surface 211 extending between the cavity 48 and the outer surface 41 (FIG. 1A). For example, as described below in connection with Figures 24A-24D, embodiments of stopper 40 can include force concentration features on annular surface 211 that cooperate with other processing or actuation components, such as, but not limited to, an insertion rod, a transfer rod, and / or a plunger rod assembly.
[0078] As will be appreciated by those skilled in the art, the ribs 42, 44 can be configured in a variety of configurations, and FIG. 7 is shown by way of example only and is not intended to limit the present disclosure. For example, in some embodiments, all of the ribs 42, 44 can have the same preset outer diameter (x). In other embodiments, each rib 42, 44 can have its own preset outer diameter (x). For example, a distal or leading rib, such as 42, can have a preset outer diameter (1x), and rib 44 can have a preset outer diameter (2x) that is about 75% to about 99.9%, about 80% to about 95%, or about 85% to about 90% of the preset outer diameter (1x).
[0079] As shown in FIG. 7, the ribs 42, 44 define a seal feature region 270 (also referred to as the seal region 270) having a length L11. The seal feature region 270 is spaced from the proximal end 210 of the stopper 40 by a seal location length L12. The distance between the proximal-most seal rib (44 in the illustrated embodiment) and the distal-most seal rib (42 in the illustrated embodiment) can be characterized as the total rib length L11. In these embodiments, since there are two seal ribs 42, 44, the total rib length L11 is interchangeable with the seal region length L11. However, in various other embodiments that may incorporate additional seal ribs, the total rib length may not be equal to the length L11 of the seal region 270.
[0080] An embodiment of the cavity 48 can be described with reference to Figure 7. As shown, the cavity 48 is a recess having an opening 260 in the proximal end 210 and an annular surface 211 in the proximal end 210 of the stopper 40.
[0081] Cavity 48 is sized and configured to receive a tip of a transfer bar insertion pin, pin tip 610 of insertion pin 600 (described below in connection with FIG. 10A ), that can be used with the transfer bar system for an assembly process and / or tip 310 of plunger rod 50 (described below in connection with FIGS. 8A and 8B ) during an assembly process and / or use of syringe 10 or cartridge tube 35. The cavity has a length L10, a diameter D10 at a distal end portion of cavity 48, and a diameter D12 at a proximal end portion of cavity 48. For example, in some embodiments, length L10 of cavity 48 can be about 2.0 mm to about 7.3 mm, about 3.7 mm to about 6.0 mm, or about 4.2 mm to about 5.0 mm. The diameter D10 can be, for example, about 1.0 mm to about 3.0 mm, about 1.0 mm to about 1.5 mm, about 1.3 mm to about 2.1 mm, or about 1.6 mm to about 1.9 mm. The diameter D12 of the cavity 48 can be, for example, about 2.3 mm to about 11.0 mm, or about 2.2 mm to about 2.4 mm.
[0082] Plunger Rod 8A and 8B show a non-limiting example of a plunger rod 50 according to some embodiments. As shown, the plunger rod 50 includes a body 302 including a proximal end portion 306 and a distal end portion 308. A tip 310 of the plunger rod 50 is coupled to the body 302 at the distal end portion 308 and configured to engage the cavity 48 (e.g., shown in FIG. 7 ) of the stopper 40. The body 302 and tip 310 have a diameter less than an inner diameter of the barrel 20 such that the plunger rod 50 can be received by and advanced or translated through the barrel 20. The proximal end portion 306 can be engaged by a user of the syringe 10 to actuate the plunger rod 50.
[0083] The distal end portion 308 of the plunger rod 50 forms a shoulder 312 having a diameter D13. The tip 310 includes an engagement portion 314 coupled to the shoulder 312 (FIG. 8B). The tip 310 can have a length L9. Some embodiments, such as those shown in FIGS. 8A and 8B, include a force concentrator, such as those shown in FIGS. 25A-25D, which are described in detail below. An engagement feature, such as, but not limited to, a helical thread 318, extends from the engagement portion 314 to engage the tip 310 with a proximal end of a stopper in the assembled syringe 10 or cartridge tube 35. The engagement portion 314 tapers from a first diameter to a smaller diameter D16 with increasing distance toward the distal end portion 308 in the illustrated embodiment. In other embodiments, the engagement portion 314 has a relatively constant diameter. The above-described embodiments of the plunger rod 50 are non-limiting and variations thereof may be incorporated into the present disclosure.
[0084] Syringe Assembly Process and Stopper Use Various methods can be used to insert the lubricant-free or substantially lubricant-free stopper into the lubricant-free cartridge tube according to the embodiments. For example, in some embodiments, a vent or insertion tube 1000 as shown in FIG. 9 can be used in combination with an insertion pin as shown in FIGS. 10A and 10B. For example, in some embodiments, the insertion tube 1000 allows the lubricant-free stopper 40 to be placed inside the lubricant-free syringe barrel or lubricant-free cartridge tube without applying excessive pressure to the liquid contained therein. As shown, the insertion tube 1000 has a proximal end 1012 and a distal end 1014. The insertion tube 1000 also includes a body 1010 and a machine adaptor 1020. The body 1010 is the portion of the insertion tube 1000 that fits into a syringe barrel, such as 20, allowing a stopper, such as 40, to be placed into the syringe barrel or cartridge tube (not shown). The transition zone 1040 is the region where the stopper 40 is compressed to a diameter D4 sufficient to fit through the distal opening 1050 of the insertion tube 1000. Thus, the stopper 40 is compressed from an uncompressed state to a compressed state as it translates through the transition zone 1040.
[0085] Thus, the diameter of the stopper 40 (not shown in FIG. 9) decreases from D5 (i.e., the diameter of the placement region 1042 or the diameter of the stopper in a substantially uncompressed state) to D4 (i.e., the diameter of the distal end of the transition zone 1040). The transition zone 1040 tapers from the placement region 1042 to the body 1010 at a taper angle B. For example, in some embodiments, the diameter D5 of the placement region 1042 is about 3 mm to about 20 mm, about 5 mm to about 15 mm, or about 7 mm to about 10 mm. In some embodiments, the taper angle B can be in the range of about 1 degree to about 20 degrees, about 5 degrees to about 20 degrees, about 1 degree to about 15 degrees, about 1 degree to about 10 degrees, about 4 degrees to about 8 degrees, or about 5 degrees to about 10 degrees.
[0086] 10A and 10B show an example of an insertion pin 600 according to some embodiments that can be used in combination with an insertion tube, such as insertion tube 1000, to insert a stopper, such as stopper 40, into the barrel 20 or cartridge tube 35. The insertion pin 600 includes a cylindrical body 602 having a distal end 606 and a proximal end 608. A pin tip 610 of the insertion pin 600 is connected to and extends from a shoulder 612 of the cylindrical body 602 and interfaces with the cavity 48 of the stopper 40 upon assembly of the cylinder 10. The proximal end 608 can be sized to mate with a machine adapter (not shown) that is used to push and translate the insertion pin 600 through an insertion tube, such as the insertion tube 1000 shown in FIG.
[0087] The cylindrical body 602 has a diameter slightly smaller than the inner diameter of the body of the insertion tube (e.g., diameter D4 of the insertion tube 1000 shown in FIG. 9). The shoulder 612 is radiused and designed to press against a surface of the stopper, e.g., the proximal end of the stopper 40, during insertion of the stopper 40 into the syringe barrel 20. In other embodiments, the shoulder 612 can include or be formed with a shape other than rounded, such as, but not limited to, a flat surface, a linear taper, a curve, a rounded shape, or multiple tapers, or can incorporate a force concentrator as described further herein. As described below, an embodiment of the insertion pin 600 can include a force concentrator on the shoulder 612 that cooperates with the proximal end of the stopper during assembly of the syringe and cartridge tube. In these embodiments, the force concentrator of the shoulder 612 can include or be formed with shapes including, but not limited to, a flat surface, a rounded surface, a linear taper, a curve, a rounded shape, or a multiple taper.
[0088] The pin tip 610 has a length L1. In some embodiments, the length L1 can be zero, greater than zero but less than the depth L10 of the cavity 48 of the stopper 40, approximately the depth L10 of the cavity 48, or greater than the depth L10 of the cavity (FIG. 7). For example, in some embodiments, the pin tip 610 has a length L1 that is approximately between about 1 mm and 12 mm, between 1 mm and 10 mm, between 2 mm and 9 mm, between 3 mm and about 8 mm, between about 4 mm and about 7 mm, between about 4.5 mm and 5.5 mm, or between about 5 mm and about 6 mm.
[0089] Stopper assembly process and stopper deformation during use The effect of compression of the stopper 40, and in particular the physical effect on the elastomeric body 125 and / or the polymer or oriented polymer layer 140 (or laminate layer 130 (not shown)), can be described with reference to FIGS. 11A-11D, 12A-12D, and 13A-13D. The following description of FIGS. 11A-11D, 12A-12D, and 13A-13D, and throughout this specification, use terms such as "tube" and related "translation element." As discussed herein, these terms are used to describe various components of the syringe 10 and the manufacturing equipment (not shown) used to assemble the syringe 10. For example, the plunger rod 50 is a "translation element" that can be used to translate the stopper 40 through a "tube" in the form of the syringe barrel 20 or cartridge tube 35 during the assembly process and / or use of the syringe 10. As another example, a vacuum funnel or vacuum assisted funnel can be used with a pin that can be a "translating element" that can be used to pass through a "tube" to translate the stopper 40 during the assembly process and / or use of the syringe 10. As another example, the insertion pin 600 is a "translating element" that can be used to pass through a "tube" in the shape of the insertion tube 1000 to translate the stopper 40 during the assembly process of the syringe 10. As yet another example, a transfer bar insertion pin is a "translating element" that can be used to pass through a "tube" in the shape of a stopper receiving opening to translate the stopper 40 during assembly of the syringe 10. Those skilled in the art will recognize that other tubes and translation elements can be used in connection with the assembly and use of the syringe 10, such as, for example, a vacuum insertion engagement tube, and the description herein also applies to these other tubes and translation elements.
[0090] FIG. 11A shows a portion of the stopper 40 including the elastomeric body 125 and the polymer or oriented polymer layer 140 before the stopper 40 is compressed. The stopper 40 can be compressed in a variety of ways including, but not limited to, a vent tube, a barrel, a vacuum funnel, a transfer bar, or any other suitable mechanism for compression. FIG. 11B is a schematic diagram showing radial compression (represented by arrows 750) of a portion of the stopper 40 during and after the assembly process, for example, after insertion into an insertion tube 1000. Although described with respect to the insertion tube 1000 in connection with FIGS. 11A-11D, 12A-12D, and 13A-13D, similar effects occur during other manufacturing steps and use of the syringe 10 as described herein. As shown by arrows 752, compression of the stopper 40 results in an elongation of a portion of the stopper 40 in a direction generally parallel to the longitudinal axis 39 of the stopper 40 and perpendicular to the compressive force applied by the insertion tube 1000. Radial compression produces a normal force FN, shown diagrammatically in FIG. 11C.
[0091] 11D illustrates certain effects on the stopper 40 as it is actuated to translate through a tube, such as the insertion tube 1000. In order for the stopper 40 to be able to slide within a tube (e.g., the insertion tube 1000), an applied force FA is required to overcome the friction force FF between the portion of the stopper 40 that engages the inner surface of the insertion tube 1000 (e.g., the sealing ribs 42, 44). The applied force (FA) can be expressed by the following equation: FA=μFN where μ is the coefficient of friction between the polymer or oriented polymer layer 140 and the inner surface of the insertion tube 1000.
[0092] FIG. 12A is a schematic diagram similar to FIG. 11C, showing a normal force FN that occurs on a radially compressed portion of the stopper 40 including the cavity 48, resulting in a non-uniform shape compared to the shape of the structure shown in FIG. 11C. FIG. 12B shows a schematic of an applied force FA that is used to overcome a frictional force FF between a portion of the stopper 40 that engages an inner surface of an insertion tube 1000 to allow the stopper 40 with the cavity 48 to slide within a tube such as the insertion tube 1000 according to some embodiments. By way of example, FIG. 12B shows a uniform applied force FA on the surfaces of the distal end portion 261 and sidewall 264 of the cavity 48 and the annular surface 211 of the proximal end 210 of the stopper 40. The force FA can be applied, for example, by the pin tip of an insertion pin as the stopper 40 is driven to translate through the insertion tube 1000.
[0093] 12C illustrates, in a schematic manner, an embodiment where an applied force FA is applied only to the distal end portion 261 of the cavity 48 (e.g., in the illustrated embodiment, no force is applied to the sidewall 264 or the face of the proximal end 210 of the stopper 40). As illustrated, the applied force FA causes the elastomeric body 125 to elongate.
[0094] FIG. 12D shows a schematic representation of an applied force FA applied to a surface of the proximal end 210 of the stopper 40 (e.g., in the illustrated example, no force is applied to surfaces of the cavity 48, such as the distal end portion 261 and / or sidewall 264). As will be explained in more detail below, the elongation, stretching or other distortion of the polymer or stretched polymer layer 140 and / or the microgrooves 133 can be controlled by such applied forces FA. The frictional force FF due to the applied force FA shown in FIG. 12D can be less than the frictional force FF due to the uniform applied force FA shown in FIG. 12B. As shown by the dashed line 754 in FIG. 12D, in the illustrated example, the applied force FA causes the elastomeric body 125 to tend to expand towards or into the cavity 48 in response to this force arrangement, reducing the normal force FN (FIG. 12A).
[0095] 13A-13B show a portion of a rib of stopper 40 having microgrooves 133 therein, with stopper 40 in an uncompressed state. When in an uncompressed state, stopper 40 is not inserted into any of the "tubes" used for compression, as previously described. Microgrooves 133 form thinned or discontinuous grooves and / or regions in polymer or oriented polymer layer 140 where rib 42 engages and is compressed by a tubular structure (e.g., insertion tube 1000). FIG. 13A is a schematic diagram of rib 42 including microgrooves 133 in polymer or oriented polymer layer 140 before rib 42 (or a stopper including rib 42) is compressed. The maximum depth of the microgrooves 133 shown in FIG. 13A (which have sloping sidewalls and a maximum depth about their center as shown) is less than the thickness of the polymer or oriented polymer layer 140, and no portion of the elastomeric body 125 is exposed to the outer surface of the polymer or oriented polymer layer 140 (with the possible exception of the elastomeric material of the elastomeric body 125 at the maximum depth portion of the microgrooves 133). FIG. 13B is a schematic diagram of a rib 42 including microgrooves 133 with sloping sidewalls as shown and a maximum depth at least as great as the thickness of the polymer or oriented polymer layer 140. The stopper 40 shown in FIG. 13B is in an uncompressed state. A length L16 of the elastomeric material of the elastomeric body 125 of the stopper 40 is exposed within the microgrooves 133 in the example shown in FIG. 13B.
[0096] The illustrated stopper 40 may be subjected to radial compression (represented by arrow 750), for example by insertion into a vent tube, barrel, cartridge, transfer bar, or any other suitable compression mechanism, resulting in elongation of the stopper 40 in a direction generally parallel to the longitudinal axis 39 of the stopper 40 and perpendicular to the compressive force applied by the tube (e.g., an insertion tube, barrel, or cartridge tube). As shown diagrammatically in FIGS. 13C and 13D, the elongation of the stopper 40, and thus the ribs 42, results in the stretching and thinning of the polymer or oriented polymer layer 140. In such an embodiment, if the ribs 42 comprise microgrooves 133, the openings of the microgrooves 133 may increase in width (e.g., width W2 shown in FIG. 4) and decrease in depth. For example, FIG. 13C illustrates a thinning of the polymer or oriented polymer layer 140 relative to the thickness shown in FIG. 13A by an amount that makes the maximum depth of the microgrooves 133 approximately equal to the thickness of the polymer or oriented polymer layer 140. Figure 13D shows the thinning of polymer or oriented polymer layer 140 relative to the thickness shown in Figure 13B. The stretching and thinning shown in Figure 13D allows the length L16 of the portion of microgrooves 133 that has a depth at least as deep as the thickness of polymer or oriented polymer layer 140 (and where the elastomeric material of elastomeric body 125 is exposed) to increase to a length L18 that is greater than L16.
[0097] 13C and 13D show, by way of example, ribs 42 of a stopper 40 having microgrooves 133 that are free of or substantially free of elastomeric body 125 material when in a compressed state (e.g., no elastomeric material is expanded, bloomed or otherwise present in the areas defined by the microgrooves 133).
[0098] It has been observed that during assembly and / or use of a stopper, such as stopper 40 in syringe 10, frictional forces and / or other forces acting on the polymer or oriented polymer layer 140 and / or elastomeric body 125 material can result in additional deformations (in addition to those shown in and described in conjunction with, e.g., FIGS. 13C and 13D ) of the polymer or oriented polymer layer 140 and / or elastomeric body 125 material. These frictional and / or other forces can also cause tension or other failures in the polymer or oriented polymer layer 140. Observed deformations include, for example, buckling and wrinkling of the outer surface 41 of stopper 40, including at ribs such as 42 and 44. These forces can occur, for example, by compression of stopper 40 from an uncompressed state to its compressed state and / or by translation or sliding of the stopper within the tube (i.e., in a direction parallel to the longitudinal axis of the tube). Such deformation and / or failure of the polymer or oriented polymer layer 140 and / or elastomeric body 125 may result in deformation, e.g., an increase in width, of the ribs 42, 44 and / or microgrooves 133 during the manufacturing process. Similarly, such deformation and / or failure of the polymer or oriented polymer layer 140 and / or elastomeric body 125 may result during use of a syringe or autoinjector.
[0099] Any or all of such deformations and / or obstructions may cause the elastomeric body 125 to bloom, expand into, or otherwise present the microgrooves 133. Such deformations and / or obstructions may cause the elastomeric body 125 to expand and contact the inner surface 25 of the tube. Similarly, portions of the polymer or oriented polymer layer 140 may peel or tear from the elastomeric body 125, such tearing or other damage may cause undesired openings in the polymer or oriented polymer layer 140. The elastomeric body 125 material may extend through such undesired openings, revealing the elastomeric material on the inner surface of the tube. This type of deformation and / or obstruction may be particularly problematic in translating the stopper 40 in the tube. Such effects may be exacerbated by factors such as increased frictional forces when the portion of the elastomeric body 125 that contacts the inner surface 25 of the tube is lubricant-free or substantially lubricant-free.
[0100] Engagement of a portion of the elastomeric body 125 of the stopper 40 with the inner surface of the tube during the assembly process and / or use of the syringe 10 may adversely affect the functionality of the associated syringe 10. For example, a gap between the outer surface of the stopper 40 and the inner surface 25 of the barrel 20 of the syringe 10 may adversely affect container closure integrity (CCI). The therapeutic compound in the syringe 10 may be exposed to undesirable substances such as air or other gases or particles that may adversely affect the therapeutic compound. Increased frictional forces between the stopper 40 and the inner surface 25 of the syringe barrel 20 may adversely affect the operation of the syringe 10, for example, by increasing the break-loose and sliding forces of the syringe 10 (or cartridge tube 35). These effects on operation may lead to non-injection or particulation of the elastomer, causing contamination, and thus causing assembly machine stoppages.
[0101] [Example of strengthening syringe] The structures and methods disclosed herein can enhance the functionality of lubricant-free or substantially lubricant-free syringes. For example, the CCI of the syringe can be increased. Exposure of the therapeutic compound in the syringe barrel to undesirable substances such as gases, exudates, reactants or other materials, such as the base body of the stopper, that may react undesirably with the contents of the syringe barrel can be reduced or minimized. Break-loose and sliding forces of the syringe during use can be reduced or minimized.
[0102] 14 illustrates certain translational forces that may be applied to the stopper 40 during assembly and use of the syringe 10. As illustrated, the translational forces may include a component such as F1 that is applied to the proximal end 210 of the stopper 40, such as against the annular surface 211, and a component such as F2 that is applied to the distal end portion 261 of the cavity 48, such as against the distal end surface 263. The structures and methods disclosed herein contemplate using and / or applying translational forces such as components F1 and / or F2 sufficient to translate the stopper 40 through a tube (e.g., a transfer bar, an insertion tube barrel 20, and / or a cartridge tube 35) relative to the stopper 40 during assembly and / or use of the syringe in a compressed state while reducing deformation of the stopper 40. Specifically, the stopper 40 may be translated while reducing the increase in length between any two sealing ribs of the stopper 40. For example, applying translational forces such as components F1 and F2 to the stopper 40 during syringe assembly according to the structures and methods herein can reduce the increase in the sum of the seal area length L11 and the seal location length L12 compared to the increase in the sum of the seal area length L11 and the seal location length L12 that occurs when using a conventional translation method. For example, the sum of the seal area length L11 and the seal location length L12 can exhibit a reduction in the increase of at least 1% of the sum of the seal area 270 length L11 and the seal location length L12 that occurs when using a conventional method. In various embodiments, the reduction in the increase can be at least 3% of the total increase that occurs when using a conventional translation method, and in further embodiments, the reduction in the increase can be at least 5% of the total increase that occurs when using a conventional translation method. Although generally described as a reduction in the increase in the sum of the seal area 270 length L11 and the seal location length L12, the reduction in the increase in length can be with respect to any length between the various ribs of the stopper or between the proximal end 210 and the distal end 215 of the stopper 40.
[0103] Additionally, by using the structures and methods described herein, the increase in size of the microgrooves 133 upon compression can be reduced or the microgrooves 133 can be completely closed. Specifically, by using the structures and methods described herein, the increase in width W2 (FIG. 4) of the microgrooves 133 can be reduced when the stopper 40 is assembled into a syringe. For example, the reduction in the increase in width W2 of the microgrooves 133 can be at least 10% of the increase in width due to the use of conventional translation methods. In various embodiments, the reduction in the increase can be at least 15% of the increase in width due to the use of conventional translation methods. Each of these results results from the translation forces on the stopper 40 being biased more toward the outer diameter of the stopper 40 due to the use of a force concentrator, as further described below. Alternatively or additionally, in some embodiments, the length L11 of the seal region 270 is reduced in increase compared to when these methods and structures are not used. These structures, such as the concentrators and methods described above, collapse the structures in the seal area 270 to partially or completely prevent deformation of the stopper 40 and / or its polymer or oriented polymer layer 140 that would expose, become more exposed, bloom, or otherwise contact a portion of the elastomeric material to the inner surface of the tube during assembly and / or use of the syringe 10. The collapse of the structures in the seal area 270 can also partially or completely prevent the increase in size, such as width W2 (FIG. 4), of the microgrooves 133. For example, the techniques described herein can close the microgrooves 133 to prevent elastomeric body 125 material from being present in the microgrooves. Although the ribs 44 are used as sealing ribs to set the seal location length L12, in various other embodiments, the sealing ribs can be other ribs of the stopper 40. For example, the stopper 40 can include additional ribs positioned along the stopper 40 that can alternatively be used as sealing ribs to set the seal location length L12. Similarly, various other ribs may be substituted for rib 42 to set length L11, seal area 270 and seal location length L12.
[0104] FIG. 15 is a side cutaway view of an insertion pin 600A that can be used with a tube for assembly of a stopper 40, for example as shown in FIG. 16. The insertion pin 600A includes a shoulder 613 defined by a diameter D6. Looking at FIGS. 15 and 16, the shoulder 613 engages the annular surface 211 of the stopper 40 upon translation of the stopper 40. A translational force F1 is thereby applied to the proximal end 210 of the stopper 40 and against the annular surface 211 of the stopper 40. In this manner, the force is concentrated on the outer diameter of the cavity 48 of the stopper 40. No force component, such as that identified as F2 in FIG. 14, is applied to the stopper 40 by the insertion pin 600A shown in FIGS. 14 and 15. However, the translational force F1 is biased toward the outer diameter of the cavity 48 by the engagement with the annular surface 211, thereby reducing deformation of the stopper 40. Specifically, the width of the microgroove 133 of the stopper 40 can decrease in increase after translation, and / or the sum of the length L11 of the sealing area 270 and the sealing location length L12 and / or the length L11 of the sealing area 270 can also decrease in increase upon translation.
[0105] 17 and 18, the insertion pin 600B can be used for translation of the stopper 40. The insertion pin 600B includes a shoulder 612 defined by a diameter D6, similar to the shoulder 613 of the insertion pin 600A, and includes a pin tip 610 extending from the shoulder 612. When used with the stopper 40, the pin tip 610 is thereby disposed within the cavity 48 without engaging the distal end portion 261 or the distal end face 263 when the face of the shoulder 612 of the insertion pin 600B engages the annular surface 211 of the stopper 40. A translation force F1 is thereby applied to the proximal end 210 of the stopper 40. Any component of a force, such as that identified as F2 in FIG. 14, is applied to the stopper 40 by the insertion pin 600B shown in FIGS. 17 and 18. The pin tip 610 enhances alignment of the stopper and the insertion pin when inserting the insertion pin 600B into the cavity 48 of the stopper 40 and / or when the insertion pin is translated during assembly of the syringe 10. Although described in connection with the insertion pin 600B being used to translate the stopper 40 through an insertion tube such as 1000, embodiments include transfer bar insertion pins having a distal end portion and flat surface similar to the insertion pin 600B and the use of such transfer bar insertion pins during assembly of the syringe 10.
[0106] 17 and 18, the stopper 40 can be translated through the tube during assembly of the syringe 10 with a reduced increase in the width W2 (FIG. 4) of the microgroove 133. For example, the reduction in the increase in the width W2 of the microgroove 133 can be at least 10% of the increase in width that occurs when using conventional translation methods. In various other embodiments, the reduction in the increase can be at least 15% of the decrease in width that occurs when using conventional translation methods. Furthermore, by using the structures and methods described herein, the stopper 40 can be translated through the tube during assembly with a reduction in the total increase of at least 1% when compared to the sum of the length L11 and the seal location length L12 of the sealing area 270 or the increase in the length of the sealing area 270 that occurs when using conventional translation methods, or a reduction in the increase in the length L11 by at least 1%. The sealing area 270 can be collapsed to reduce the length L11 and the seal location length L12 of the sealing area 270 by such manufacturing methods.
[0107] FIG. 19 is a diagram of a retractable tip insertion pin 600C according to some embodiments. As shown, the insertion pin 600C has a pin tip 610 at a distal end of a retraction member 615. The pin tip 610 has a diameter W3 that is less than the diameter of the cavity 48 of the stopper 40 (e.g., D12 shown in FIG. 7). For example, the diameter W3 can have a value less than or equal to 50% of the diameter of the cavity 48. In another embodiment, the diameter W3 can have a value between 5% and 50% of the diameter of the cavity 48. In yet another embodiment, the diameter W3 can have a value between 15% and 40% of the diameter of the cavity 48 of the stopper 40. The retraction member 615 and the pin tip 610 are mounted for retraction and reciprocation within the body 602. An actuator 617 associated with the insertion pin 600C drives the retraction member 615 and the pin tip 610 between a retracted position (shown in solid lines) and an extended position (shown in dashed lines). In the retracted position, the pin tip 610 extends a length L1 from the shoulder 612 of the body 602. In the extended position, the pin tip 610 extends a length L2 from the shoulder 612 of the body 602. In some embodiments, the length L1 of the pin tip 610 in the retracted position is less than the depth L10 of the cavity 48 of the stopper 40. In some embodiments, the length L2 of the pin tip 610 in the extended position is greater than or equal to the depth L10 of the cavity 48 of the stopper 40.
[0108] The actuator 617 may be any device suitable for driving the retraction member 615 and / or the pin tip 610 between retracted and extended positions relative to the body 602. Examples include an electrical device such as a solenoid or a hydraulic or pneumatic device. Although shown generally as being on the body 602 in the illustrated embodiment, the actuator 617 and / or actuator components (not shown) associated with the insertion pin 600C may be separate from the body 602. Conventional or other known control systems may be used to control the actuator 617.
[0109] FIG. 20A illustrates engagement of the insertion pin 600C with the proximal end 210 of the stopper 40 during assembly of the syringe 10 when the pin tip 610 is in the retracted position. As shown, the pin tip 610 rests in the cavity 48 without engaging the distal end portion 261, and the face of the shoulder 612 engages the annular surface 211 of the stopper 40. This applies a translational force F1 to the proximal end 210 of the stopper 40. No force component (such as that identified as F2 in FIG. 20B) is applied to the stopper 40 by the insertion pin 600C when the pin tip 610 is in the retracted position. The pin tip 610 can enhance alignment of the insertion pin 600C with the stopper 40 when inserting the pin tip 610 into the cavity 48 of the stopper 40 and / or translating the insertion pin 600C during assembly of the syringe 10 when the pin tip 610 is in the retracted position.
[0110] 20B illustrates engagement of the insertion pin 600C with the stopper 40 during assembly of the syringe 10 when the pin tip 610 is in the extended position. The pin tip 610 is thereby positioned within the cavity 48 and engages the distal end portion 261 (e.g., distal end face 263) of the cavity when the face of the shoulder 612 of the insertion pin 600C engages the annular surface 211 of the stopper 40. This causes a translational force F2 to be exerted by the pin tip 610 on the distal end portion 261 of the stopper 40 as the insertion pin 600C translates the stopper 40. The amount of force F2 exerted by the pin tip 610 on the distal end portion 261 of the cavity 48 when in the extended position can be determined, at least in part, by the difference between the length L2 of the pin tip 610 when in the extended position and the depth L10 of the cavity. The amount of force F2 exerted by pin tip 610 on stopper 40 during translation of the stopper can thereby be controlled by actuation of pin tip 610 by actuator 617.
[0111] For example, in some embodiments, the force F2 exerted by the pin tip 610 during translation of the stopper 40 ranges from zero to greater than or equal to F1. In some embodiments, the insertion force component F2 is a force less than F1. The timing at which the insertion force component F2 is applied can also be controlled. For example, in some embodiments, the force component F2 is applied initially (e.g., before the stopper "breaks loose" and begins to slide within the insertion tube 1000), and the force component F2 can be reduced (e.g., reduced to zero by retracting the pin tip 610) or reduced to a non-zero level. Yet another embodiment can include a pressure sensor (not shown) that can monitor the force components F1 and F2, and the actuator 617 can be operated to retract the pin tip 610 and reduce the force component F2 when a preset trigger force is reached. The relative ratio of the force components F1 and F2 can thereby be controlled. The relative application timing of the force component F2 compared to the force F1 during translation of the stopper 40 can also be controlled. The dynamic relationship between forces F1 and F2 can be imparted at various stages of translation of the stopper 40 within the insertion tube 1000. For example, forces F1 and / or F2 applied to the stopper 40 when the stopper 40 is initially inserted into the placement region 1042 of the insertion tube 1000 ( FIG. 9 ) may be different than forces F1 and / or F2 applied to the stopper 40 as the stopper 40 translates through the transition zone 1040. In some embodiments, other forces F1 and / or F2 are applied to the stopper 40 as the stopper 40 translates through the body 1010 of the insertion tube 1000.
[0112] Although described in connection with an insertion pin 600C used to translate the stopper 40 through an insertion tube such as 1000, embodiments include transfer bar insertion pins having retractable pins, such as the retractable pin of the insertion pin 600C, and the use of such transfer bar insertion pins during assembly of the syringe 10. By using the structures and methods described in connection with FIGS. 19, 20A, and 20B, the stopper 40 can be translated through the tube during assembly of the syringe 10 while reducing the increase in size, such as width W2 (FIG. 4), of the microgrooves 133 of the stopper 40. In some embodiments, the reduction in the increase in size, such as width W2, of each microgroove 133 can be at least 10% of the increase in width that occurs when using conventional translation methods. In some embodiments, the reduction in the increase can be at least 15% of the increase in width that occurs when using conventional translation methods. Additionally, the stopper 40 can be translated while reducing the increase in the sum of the length L11 of the sealing area 270 and the sealing location length L12, or the increase in the length L11 of the sealing area 270, by at least 1% of the increase in the sum or length L11 that occurs when using conventional translation methods. In some embodiments, the reduction in the increase is at least 3%, and in yet other embodiments, the reduction in the increase is at least 5% of the increase in the sum or length L11 that occurs when using conventional translation methods. The sum of the length L11 of the sealing area 270 and the sealing location length L12, or the length L11 of the sealing area 270, can be reduced by this approach compared to not using a force concentrator. The sealing area 270 can be collapsed and the length of the sealing area 270 can be reduced by assembling and using the syringe 10 (and the cartridge tube 35 of the autoinjector) as described herein.
[0113] FIG. 21 is a diagram of an insertion pin 600D according to some embodiments. As shown, the insertion pin 600D has a pin tip 610 at the end of a retraction member 615. The pin tip 610 has a diameter W3 that is smaller than the diameter of the cavity 48 of the stopper 40 (e.g., D12 in FIG. 7). The retraction member 615 and the pin tip 610 are mounted for retraction and reciprocation within a cavity in the body 602, e.g., the cavity 48. A biasing device, such as a spring 619, biases the retraction member 615 and the pin tip 610 to an extended position, as shown in FIGS. 22A-22B.
[0114] FIG. 22A illustrates the engagement of the proximal end 210 of the stopper 40 with the insertion pin 600D when the syringe 10 is assembled, with the pin tip 610 in the extended position. FIG. 22B illustrates the engagement of the insertion pin 600D with the stopper 40 when the syringe 10 is assembled, with the pin tip 610 in the retracted position. The retraction member 615 and the pin tip 610 can be pushed or pressed into the body 602 to the retracted position against the biasing force provided by the spring 619. In the extended position, the pin tip 610 extends from the shoulder 612 of the body 602 by a length L3 that is greater than the depth L10 of the cavity 48 of the stopper 40. As shown in FIG. 22B, in the retracted position, the pin tip 610 extends from the shoulder 612 of the body 602 by a length that is less than or equal to the depth L10 of the cavity 48 of the stopper 40. In some embodiments, the pin tip 610 is configured such that the length of the pin tip 610 extending from the body 602 is retractable into the body 602 a distance less than the depth L10 of the cavity 48 to accommodate compliance variations in the manufacturing process.
[0115] As shown in FIG. 22A, when the insertion pin 600D moves or translates into engagement with the proximal end 210 of the stopper 40, the pin tip 610 enters the cavity 48 and engages the distal end portion 261 (e.g., distal end face 263) of the cavity 48 before the shoulder 612 of the body 602 engages the annular surface 211 of the proximal end 210 of the stopper 40. This action allows the pin tip 610 to improve alignment of the insertion pin 600D with the stopper 40. As shown in FIG. 22B, by advancing or translating the insertion pin 600D further toward the stopper 40, the shoulder 612 of the insertion pin 600D engages the annular surface 211 of the proximal end 210 of the stopper 40, which urges the pin tip 610 back into the body 602 against the biasing force of the spring 619 toward a retracted position. The pin tip 610 thereby exerts a force F2 on the distal end portion 261 of the cavity 48. The amount of force F2 is determined by the spring 619. By advancing the insertion pin 600D further, the insertion pin 600D exerts a force F1 on the proximal end 210 of the stopper 40. When the sum of the forces acting on the stopper 40, including F1 and F2, is sufficient to overcome the frictional forces acting on the stopper 40, the stopper 40 translates through the insertion tube 1000. In some embodiments, the force F2 is less than the force F1. In some embodiments, the insertion pin 600D can operate differently than the insertion pin 600C described above, for example, by exerting a constant force F2 on the stopper 40 throughout the entire period of translation of the stopper 40 while exerting force F1.
[0116] Although described in connection with the insertion pin 600D used to translate the stopper 40 through an insertion tube such as 1000, embodiments include transfer bar insertion pins having biasing pins, such as the biasing pin of the insertion pin 600D, and the use of such transfer bars in the assembly of the syringe 10. By using the structures and methods described in connection with Figures 21, 22A and 22B, the stopper 40 can be translated through the tube during assembly of the syringe 10 while reducing the increase in size, e.g., width W2 (Figure 4), of the microgrooves 133 of the stopper 40. In some embodiments, the reduction in the increase in size, e.g., width W2, of each microgroove 133 can be at least 10% of the increase in width that occurs when using conventional translation methods. In some embodiments, the reduction in the increase can be at least 15%. 21, 22A, and 22B, the stopper 40 can be translated through the tube when the syringe 10 is assembled while the increase in the sum of the length L11 of the sealing area 270 and the sealing location length L12, or the increase in the length L11 of the sealing area 270, is reduced by at least 1% of the increase in the sum or length L11 that occurs when using conventional translation methods. In another embodiment, the stopper 40 can be translated through the tube when the syringe 10 is assembled while the increase in the sum of the length L11 of the sealing area 270 and the sealing location length L12, or the increase in the length L11 of the sealing area 270, is reduced by at least 3%. In another embodiment, the reduction in increase can be at least 5% of the increase in the sum or length L11 that occurs when using conventional translation methods. The sum of the length L11 of the sealing area 270 and the sealing location length L12 and / or the length L11 of the sealing area 270 can be reduced by these techniques. The seal area 270 collapses and the length of the seal area 270 is reduced by these manufacturing techniques compared to when these manufacturing techniques are not used.
[0117] 23A-23D each illustrate an insertion pin 600E-600H according to some embodiments. As shown, the insertion pins 600E-600H each include an example of a force concentrator 621E-621H extending from a shoulder 612 about the pin tip 610. The force concentrators 621E-621H are positioned to engage an annular surface 211 of the proximal end 210 of the stopper 40 during assembly of the syringe 10. As the insertion pins 600E-600H move toward the stopper 40 during assembly of the syringe 10, the surface 623 of the force concentrators 621E-621H, respectively, engages a portion of the annular surface 211 of the stopper 40 before another surface portion of the shoulder 612 engages the proximal end of the stopper 40. The force concentrators 621E-621H have a width that is less than the width of the area of the insertion pin 600E-600H around the pin tip 610 and less than the width of the annular surface 211 (e.g., the portion of the distal end portion 261 around the cavity 48). The force concentrators 621E-621H thereby concentrate the application of force F1 to the locations on the annular surface 211 with which they engage. The force concentrators are configured to bias the applied force towards the outer diameter of the stopper 40, thereby reducing or eliminating the amount that the microgrooves 133 open upon compression.
[0118] In some embodiments, only the force concentrators 621E-621H engage the proximal end 210 of the stopper 40 as the stopper 40 translates, and in such embodiments, force F1 is applied to the annular surface 211 of the stopper only where the force concentrators 621E-621H engage. In other embodiments, the insertion pin 600E-600H can be configured such that a portion of the shoulder 612, in addition to the force concentrators 621E-621H, engages the proximal end 210 of the stopper 40 as the stopper 40 translates, and in such embodiments, a force is applied to the stopper by the insertion pin 600E-600H in addition to the concentrated force F1 applied by the force concentrators 621E-621H to translate the stopper 40.
[0119] The force concentrators 621E-621H are generally annular or ring-shaped when viewed from the distal end of the insertion pin 600E-600H. In some embodiments, the force concentrators 621E-621H extend continuously around the pin tip 610. In other embodiments, the force concentrators 621E-621H are discontinuous and include a plurality of spaced apart sections (not shown in FIGS. 23A-23D ) extending around the pin tip 610 that engage the annular surface 211 of the stopper 40 at a plurality of discrete locations around the cavity 48. The height of the force concentrators 621E-621H (e.g., relative to the plane of the portion of the shoulder 612 from which the concentrator extends) and the location of the force concentrators 621E-621H (e.g., the location on the annular surface 211 of the stopper that the force concentrator engages) and / or the profile or shape of the force concentrators 621E-621H can be configured to provide a desired amount of concentrated force F1 at a desired location on the stopper 40.
[0120] FIG. 23A illustrates a force concentrator 621E having a generally flat surface 623 according to some embodiments. In the embodiment illustrated in FIG. 23A, the force concentrator 621E has a generally rectangular cross-section. The width of the surface 623 of the force concentrator 621E can be configured to provide a desired concentrated force F1. In the illustrated embodiment, the concentrated force F1 is provided at a location on the annular surface 211 inboard from the outer periphery of the stopper 40. In another embodiment, the force concentrator 621E illustrated in FIG. 23A can be positioned to provide a concentrated force around the periphery of the annular surface 211 of the stopper 40.
[0121] FIGURE 23B illustrates a force concentrator 621F having a generally knife-edge shaped or sharp surface 623 according to some embodiments. In the embodiment illustrated in FIGURE 23B, the force concentrator 621F has a generally triangular cross-section. The slope of the surface 623 of the force concentrator 621F can be configured to provide a desired concentrated force F1. The apex of the force concentrator 621F is positioned on the insertion pin 600F to engage the annular surface 211 of the stopper 40 at a location between the outer edge of the cavity 48 and the outer edge of the annular surface 211.
[0122] 23C illustrates a force concentrator 621G having a generally knife-edge shaped or sharp surface 623 according to some embodiments. Force concentrator 621G is similar to force concentrator 621F described above, except that an apex of force concentrator 621G is positioned on insertion pin 600G to engage annular surface 211 of stopper 40 at an outer edge portion of annular surface 211.
[0123] FIG. 23D illustrates a force concentrator 621H having a generally rounded or convex surface 623.
[0124] Although described with reference to insertion pins 600E-600H used to translate stopper 40 through an insertion tube such as 1000, embodiments include transfer bar insertion pins having force concentrators substantially the same as or similar to force concentrators 621E-621H, and the use of such transfer bar insertion pins during assembly of syringe 10. Similarly, force concentrators substantially the same as or similar to force concentrators 621E-621H can be incorporated into shoulder 312 of plunger rod 50 (e.g., as described above in connection with FIGS. 8A and 8B and shown in FIGS. 25A-25D) in addition to or in place of force concentrator 330. Force concentrators 621E-621H can also be incorporated into insertion pins 600A-600D described above in connection with FIGS. 17-19, 20A, 20B, 21, 22A, and 22B. By using the structures and methods described in connection with FIGS. 23A-23D, the stopper 40 can be translated through a tube during assembly of the syringe 10 while reducing the increase in size, e.g., width W2 (FIG. 4), of the microgrooves 133 of the stopper 40. For example, the reduction in the increase in width W2 of the microgrooves 133 can be at least 10% of the increase in width that would occur using conventional translation methods. In another example, the reduction in the increase in width W2 can be at least 15% of the increase in width that would occur using conventional translation methods. Furthermore, in use, the structures and methods described herein can translate the stopper 40 through a tube during assembly of the syringe 10 while reducing the increase in the sum of the length L11 of the sealing area 270 and the sealing location length L12, or the increase in the length L11 of the sealing area 270, by at least 1% of the increase in the sum or length L11 that would occur using conventional translation methods. In another embodiment, the reduction in the sum of the length L11 and the seal location length L12 of the sealing area 270 or the increase in the length L11 of the sealing area 270 can be at least 3%, or in another embodiment, at least 5%, of the increase in the sum or length L11 that occurs when using conventional translation methods. The sum of the length L11 and the seal location length L12 of the sealing area 270 and / or the length L11 of the sealing area 270 can be reduced by these techniques. By such manufacturing methods, the sealing area 270 can be collapsed to reduce the length of the sealing area 270.As mentioned above, the size of the microgrooves 133 can also be reduced by such techniques.
[0125] 24A-24D show stoppers 40A-40D, respectively, according to some embodiments. As shown, stoppers 40A-40D include force concentrators 47A-47D, respectively, that extend from a portion of annular surface 211 of proximal end 210 around cavity 48. Although shown as being used separately in FIGS. 24A-24D, force concentrators 47A-47D can be used in combination in a single stopper. For example, in one example, force concentrators 47A and 47B can both be used in a single stopper 40. In another example, any combination of force concentrators 47A-47D can be used in stopper 40. Force concentrators 47A-47D are positioned to engage a distal surface of structure that is used to translate stopper 40 through a tube during assembly and use of syringe 10, including stopper 40. For example, the force concentrators 47A-47D can engage a distal end, such as shoulder 612 of the insertion pin 600 and / or a shoulder of the transfer bar insertion pin during assembly of the syringe 10, and / or shoulder 312 of the plunger rod 50 during use of the syringe 10 (e.g., as described in connection with FIGS. 10A and 10B and shown in FIGS. 25A-25D). When the structure that engages and translates the stoppers 40A-40D moves toward the stoppers during assembly of the syringe 10, a face at the distal end of the structure engages the force concentrators 47A-47D before engaging other portions of the annular surface 211 at the distal end of the stoppers 40A-40D. The force concentrators 47A-47D have a width that is less than the width of the portion of the annular surface 211 around the cavity 48. The force concentrators 47A-47D thereby concentrate the application of force F1 at the location of the force concentrators 47A-47D when engaging structure that translates the stoppers 40A-40D, respectively, during assembly and / or use of the syringe 10. In some embodiments, only the force concentrators 47A-47D engage structure that translates the stoppers 40A-40D, respectively, during assembly and / or use of the syringe 10, and force F1 is applied to the proximal end 210 of the stopper only at the location of the force concentrators 47A-47D.In other embodiments, the structure for translating stoppers 40A-40D engages portions of annular surface 211 of proximal end 210 in addition to force concentrators 47A-47D as stopper 40 translates, and in such embodiments, the force applied to concentrated force F1 applied through force concentrators 47A-47D is applied to stopper 40 by the structure for translating stopper 40.
[0126] The force concentrators 47A-47D are generally annular or ring-shaped when viewed from the proximal end of the stopper 40A-40D. In some embodiments, the force concentrators of FIGS. 24A-24D extend continuously around the proximal end 210 of the stopper 40A-40D. In other embodiments, the force concentrators of FIGS. 24A-24D are discontinuous and include multiple spaced apart sections (not shown in FIGS. 24A-24D) extending around the proximal end 210 that engage the translation structure at multiple discrete locations. In other embodiments, the force concentrators 47A-47D are present at the distal end portion 308 of the plunger rod 50 as shown in FIGS. 25A-25D.
[0127] It should be appreciated that the force concentrators shown in Figures 25A-25D are the same or substantially the same shape and size as the force concentrators shown in Figures 23A-23D and / or 24A-24D. The height of force concentrators 47A-47D, 621E-621H (e.g., relative to annular surface 211 from which it extends), the location of the force concentrator (e.g., relative to cavity 48 and / or the outer edge of annular surface 211) and / or the profile or shape of the force concentrator can be configured to provide a desired amount of concentrated force F1 at a desired location on the stopper.
[0128] FIG. 24A illustrates a force concentrator 47A having a generally flat surface 49 according to some embodiments. In the embodiment illustrated in FIG. 24A, the force concentrator 47A has a generally rectangular cross-section. The width of the surface 49 of the force concentrator 47A can be configured to provide a desired concentrated force F1. In some embodiments, the concentrated force F1 is provided at a location on the annular surface 211 inboard from the outer periphery of the annular surface 211. In other embodiments, the force concentrator 47A can be positioned to provide a concentrated force around the periphery of the annular surface 211 of the stopper 40A.
[0129] FIGURE 24B illustrates force concentrator 47B having a surface 49 that is generally knife-edge shaped or sharp-angled according to some embodiments. In the embodiment illustrated in FIGURE 24B, force concentrator 47B has a generally triangular cross-section. The slope of surface 49 of force concentrator 47B can be configured to provide a desired concentrated force F1. An apex of force concentrator 47B is located between an outer edge of cavity 48 and an outer edge of annular surface 211.
[0130] 24C illustrates force concentrator 47C having a generally knife-edge shaped or acute angled surface 49 according to some embodiments. Force concentrator 47C is similar to force concentrator 47B described above, except that the apex of force concentrator 47C is located at the outer edge of annular surface 211.
[0131] FIG. 24D illustrates a force concentrator 47D in which surface 49 is generally rounded or convex.
[0132] By using the structures and methods described in conjunction with FIGS. 24A-24D, the stoppers 40A-40D can be translated through the tube during assembly of the syringe 10 while reducing the increase in size, e.g., width W2 (FIG. 4), of the microgrooves 133 of the stoppers 40. For example, the reduction in the increase in width W2 of the microgrooves 133 can be at least 10% of the increase in width that occurs when using conventional translation methods. In another embodiment, the reduction in the increase in width W2 can be at least 15% of the increase in width that occurs when using conventional translation methods. Furthermore, by using the structures and methods described in conjunction with FIGS. 24A-24D, the stoppers 40A-40D can be translated through the tube during assembly of the syringe 10 while reducing the increase in the sum of the length L11 and the seal location length L12 of the seal area 270 or the increase in the length of the seal area 270 by at least 1% of the increase in the sum or length L11 that occurs when using conventional translation methods. In another embodiment, the reduction in growth can be at least 3%, and in another embodiment, the reduction in growth can be at least 5%. The sum of the length L11 of the sealing area 270 and the seal location length L12 or the length L11 of the sealing area 270 can be reduced by these techniques. The sealing area 270 can be collapsed and the length of the sealing area 270 can be reduced by these manufacturing methods.
[0133] 25A-25D show additional embodiments of a plunger rod having a force concentrator for use in translating the stopper 40 (FIG. 7). Specifically, FIG. 25A shows a plunger rod 50 having a tip 310 extending from a distal end portion 308 of the plunger rod 50. Additionally, the plunger rod 50 includes a force concentrating feature 330A extending from the distal end portion 308 and positioned adjacent the tip 310. As shown, the force concentrator 330A has a rectangular or square shape, although various other configurations can be incorporated. For example, FIG. 25B shows an additional embodiment of a plunger rod 50 having a force concentrator 330B shown as an annular edge portion of the distal portion 308 positioned around the pin tip 310.
[0134] 25C illustrates another variation of the plunger rod 50 having a force concentrator 330C. In the embodiment of FIG. 25C, the force concentrator 330C illustrated is a triangular protrusion extending from the end of the distal portion 308 of the plunger rod 50.
[0135] 25D illustrates another embodiment of the plunger rod 50 having a force concentrator 330D. In this embodiment, the force concentrator 330D is a rounded protrusion extending from the distal portion 308 of the plunger rod 50. However, the shapes and configurations of the force concentrators 330A-330D can be a variety of shapes, including, but not limited to, flat surfaces, linear tapers, curved, rounded, or multiple tapers.
[0136] The invention of this application has been described both generally and with reference to specific embodiments. It should be understood that those skilled in the art can make various modifications and changes to the embodiments without departing from the scope of the present disclosure. Therefore, it is intended that the embodiments cover the modifications and variations of the present invention provided they fall within the scope of the claims and their equivalents. (Aspect) (Aspect 1) 1. A method comprising: placing a distal end of a stopper on a proximal end of an insertion tube, the insertion tube and the stopper being silicone free, the stopper including a plunger rod engaging cavity and a seal area having a length spaced from the proximal end of the stopper by a seal location length, the seal area having at least one rib including at least one microgroove in a polymer barrier, the at least one microgroove having an initial width; positioning an insertion pin at a proximal end of the stopper without contacting a distal region of the plunger rod engaging cavity, the insertion pin having a cylindrical body including a distal end having a shoulder and a pin tip having a diameter smaller than a diameter of the plunger rod engaging cavity; contacting the proximal end of the stopper with the shoulder of the insertion pin; applying a force to the proximal end of the insertion pin such that a reduction in the increase in the initial width of the at least one microgroove is at least 10%; A method comprising: (Aspect 2) 2. The method of claim 1, wherein the method further comprises guiding the stopper through the entire length of the insertion tube and into a syringe barrel, the syringe barrel being silicone-free. (Aspect 3) 3. The method of claim 2, wherein the insertion pin engages the distal end region of the plunger rod engagement cavity when guiding the stopper through the insertion tube. (Aspect 4) Aspect 4. The method of any one of aspects 1 to 3, wherein in the step of placing the distal end of the stopper on the proximal end of the insertion tube, the stopper is in an uncompressed state. (Aspect 5) A method according to any one of aspects 2 to 4, wherein in the step of guiding the stopper through the insertion tube, the stopper is in a compressed state. (Aspect 6) 6. The method of any one of aspects 1-5, wherein applying the force to the proximal end of the insertion pin further comprises transmitting at least a portion of the force to the proximal end of the stopper. (Aspect 7) The method of claim 6, wherein transmitting at least a portion of the force to the proximal end of the stopper includes applying one or both of: (1) a first force to the proximal end of the stopper, or (2) a second force to the distal region of the plunger rod engagement cavity. (Aspect 8) A method according to any of the preceding aspects, wherein the shoulder of the insertion pin comprises at least one force concentrating feature comprising an annular structure extending from the shoulder of the insertion pin, optionally including at least one of a flat, angled, or rounded surface configured to engage the proximal end of the stopper. (Aspect 9) The method of any of aspects 1-8, wherein the proximal end of the stopper includes at least one force concentrating feature including an annular structure extending from the proximal end of the stopper optionally including at least one of a flat, sharp, or rounded surface configured to engage the insertion pin. (Aspect 10) 10. The method of any one of claims 8 to 9, wherein the at least one concentration feature is configured such that the force applied to the stopper is applied to at least an annular surface at the proximal end of the stopper such that the force applied to the stopper is biased toward an outer diameter of the stopper. (Aspect 11) 11. The method of any one of aspects 1-10, wherein the sealing region includes a first rib and a second rib, and applying the force to the proximal end of the insertion pin is such that an increase in length between the first rib and the second rib is reduced by at least 1%. (Aspect 12) 12. The method of any one of the preceding embodiments, wherein the reduction in the increase in the initial width of the microgroove is at least 15%. (Aspect 13) 1. A method of dispensing contents of a syringe barrel, comprising: inserting a plunger rod into a proximal end of a plunger rod engaging cavity of a stopper, the stopper being silicone free, the stopper having a proximal end and an opposing distal end, and a seal region having a length spaced from the proximal end by a seal location length, the seal region including a polymer barrier and at least one microgroove having an initial width and positioned within the polymer barrier; contacting the proximal end of the stopper against a shoulder of the plunger rod within the syringe barrel without contacting a distal region of the plunger rod engagement cavity, the syringe barrel being silicone free and containing a therapeutic agent; applying a force to the plunger rod such that a reduction in the increase in the initial width of the at least one microgroove is at least 10%; A method comprising: (Aspect 14) 14. The method of embodiment 13, further comprising guiding the stopper through the syringe barrel by transmitting at least a portion of the force applied to the plunger rod to the proximal end of the stopper. (Aspect 15) The method of embodiment 14, wherein the shoulder of the plunger rod includes at least one force concentrating feature including an annular structure extending from the shoulder of the plunger rod, optionally including at least one of a flat, sharp, or rounded surface configured to engage the proximal end of the stopper. (Aspect 16) The method of embodiment 14, wherein the proximal end of the stopper includes at least one force concentrating feature including an annular structure extending from the proximal end of the stopper, optionally including at least one of a flat, sharp, or rounded surface configured to engage the shoulder of the plunger rod. (Aspect 17) A method according to any one of aspects 14 to 16, wherein the plunger rod includes a distal end having the shoulder and a plunger rod tip, the plunger rod tip configured to be received by a distal region of the plunger rod engagement cavity of the stopper. (Aspect 18) 18. The method of embodiment 17, wherein the plunger rod tip engages the distal region of the plunger rod engagement cavity of the stopper when guiding the stopper through the syringe. (Aspect 19) The method of embodiment 18, wherein applying the force to the plunger rod includes applying one or both of: (1) a first force to the proximal end of the stopper or (2) a second force to a distal end of the plunger rod engagement cavity. (Aspect 20) A method according to any one of aspects 13 to 19, wherein the sealing area of the stopper includes a first rib and a second rib, a rib length extending between the first rib and the second rib, and the force is applied to the plunger rod such that the rib length reduces with increasing by at least 1%. (Aspect 21) 21. The method of any one of aspects 13-20, wherein the reduction in the increase in the initial width of the microgroove is at least 15%. (Aspect 22) 14. The method of embodiment 13, wherein the stopper and the plunger rod are not directly attached. (Aspect 23) Aspect 20. The method of any one of aspects 16-19, wherein the at least one force concentration feature is configured such that the force applied to the stopper is applied to at least an annular surface at the proximal end of the stopper such that the force applied to the stopper is biased toward an outer diameter of the stopper. (Aspect 24) 24. The method of any one of aspects 13-23, wherein the method further comprises delivering the therapeutic agent contained within the syringe barrel. (Aspect 25) 25. The method of any one of aspects 13 to 24, wherein the stopper is in a compressed state.
Claims
1. 1. A method comprising: placing a distal end of a stopper on a proximal end of an insertion tube, the insertion tube and the stopper being silicone free, the stopper including a plunger rod engaging cavity and a seal area having a length spaced from the proximal end of the stopper by a seal location length, the seal area having at least one rib including at least one microgroove in a polymer barrier, the at least one microgroove having an initial width; positioning an insertion pin at a proximal end of the stopper without contacting a distal region of the plunger rod engaging cavity, the insertion pin having a cylindrical body including a distal end having a shoulder and a pin tip having a diameter smaller than a diameter of the plunger rod engaging cavity; contacting the proximal end of the stopper with the shoulder of the insertion pin, the shoulder of the insertion pin comprising at least one force concentrating feature including an annular structure extending from the shoulder of the insertion pin, optionally including at least one of a flat, sharp, or rounded surface configured to engage the proximal end of the stopper; applying a force to the at least one force concentrating feature such that the force is biased toward an outer diameter of the stopper such that the force applied to the stopper is applied to at least an annular surface of the proximal end of the stopper; A method comprising:
2. 10. The method of claim 1, further comprising guiding the stopper through the entire length of the insertion tube and into a syringe barrel, the syringe barrel being silicone-free.
3. The method of claim 2 , wherein the insertion pin engages a distal end of the plunger rod engagement cavity when guiding the stopper through the insertion tube.
4. The method of any one of claims 1 to 3, wherein in the step of placing the distal end of the stopper on the proximal end of the insertion tube, the stopper is in an uncompressed state.
5. The method of any one of claims 2 to 4, wherein in the step of guiding the stopper through the insertion tube, the stopper is in a compressed state.
6. The method of any one of claims 1 to 5, wherein applying the force to the proximal end of the insertion pin further comprises transmitting at least a portion of the force to the proximal end of the stopper.
7. 7. The method of claim 6, wherein transmitting at least a portion of the force to the proximal end of the stopper comprises applying one or both of: (1) a first force to the proximal end of the stopper; or (2) a second force to the distal region of the plunger rod engagement cavity.
8. 8. The method of any of claims 1-7, wherein the proximal end of the stopper includes at least one force concentrating feature including an annular structure extending from the proximal end of the stopper, optionally including at least one of a flat, sharp, or rounded surface configured to engage the insertion pin.
9. 1. A method of dispensing contents of a syringe barrel, comprising: inserting a plunger rod into a proximal end of a plunger rod engaging cavity of a stopper, the stopper being silicone free and having a proximal end and an opposing distal end and a seal region having a length spaced from the proximal end by a seal location length, the seal region including a polymer barrier and at least one microgroove having an initial width and positioned within the polymer barrier; contacting the proximal end of the stopper against a shoulder of the plunger rod within the syringe barrel without contacting a distal region of the plunger rod engagement cavity, the syringe barrel being silicone-free and containing a therapeutic agent, the shoulder of the plunger rod comprising at least one force concentrating feature including an annular structure extending from the shoulder of the plunger rod, optionally including at least one of a flat, sharp, or rounded surface configured to engage the proximal end of the stopper; applying a force to the at least one force concentrating feature such that the force is biased toward an outer diameter of the stopper such that the force applied to the stopper is applied to at least an annular surface of the proximal end of the stopper; A method comprising:
10. 10. The method of claim 9, further comprising guiding the stopper through the syringe barrel by transmitting at least a portion of the force applied to the plunger rod to the proximal end of the stopper.
11. The method of claim 10 , wherein the plunger rod includes a distal end having the shoulder and a plunger rod tip, the plunger rod tip configured to be received by a distal region of the plunger rod engagement cavity of the stopper.
12. 12. The method of claim 11, wherein the plunger rod tip engages the distal region of the plunger rod engagement cavity of the stopper when guiding the stopper through the syringe barrel.
13. 13. The method of claim 12, wherein applying the force to the plunger rod comprises applying one or both of: (1) a first force to the proximal end of the stopper or (2) a second force to a distal end of the plunger rod engagement cavity.
14. 14. The method of claim 9, wherein the sealing area of the stopper includes a first rib and a second rib, a rib length extending between the first rib and the second rib, and the force is applied to the plunger rod such that the rib length reduces an increase by at least 1%.
15. The method of claim 9 , wherein the stopper and the plunger rod are not directly attached.
16. The method of any one of claims 9 to 15, further comprising delivering the therapeutic agent contained within the syringe barrel.
17. The method according to any one of claims 9 to 16, wherein the stopper is in compression.
Citation Information
Patent Citations
Syringe Plunger Assembly
JP2019501735A
Plunger Assembly Including a Plunger Rod for Advancing a Stopper Through a Syringe
US20150209521A1
A method of inserting a lubricant free stopper into a lubricant free barrel or a lubricant free cartridge tube and a system for assembling same
WO2020112612A1
Improved syringe and gasket systems
WO2020118275A1
